NO20074885L - N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus - Google Patents

N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus

Info

Publication number
NO20074885L
NO20074885L NO20074885A NO20074885A NO20074885L NO 20074885 L NO20074885 L NO 20074885L NO 20074885 A NO20074885 A NO 20074885A NO 20074885 A NO20074885 A NO 20074885A NO 20074885 L NO20074885 L NO 20074885L
Authority
NO
Norway
Prior art keywords
respiratory syndrome
syndrome virus
porcine reproductive
protein mutants
virus
Prior art date
Application number
NO20074885A
Other languages
English (en)
Norwegian (no)
Inventor
Dongwan Yoo
Changhee Lee
Jay Gregory Calvert
Siao-Kun Welch
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20074885L publication Critical patent/NO20074885L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10061Methods of inactivation or attenuation
    • C12N2770/10062Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20074885A 2005-02-25 2007-09-25 N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus NO20074885L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65652305P 2005-02-25 2005-02-25
US73066305P 2005-10-27 2005-10-27
PCT/IB2006/000376 WO2006129139A1 (en) 2005-02-25 2006-02-13 N protein mutants of porcine reproductive and respiratory syndrome virus

Publications (1)

Publication Number Publication Date
NO20074885L true NO20074885L (no) 2007-11-22

Family

ID=36218763

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074885A NO20074885L (no) 2005-02-25 2007-09-25 N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus

Country Status (15)

Country Link
US (3) US7544362B1 (ko)
EP (1) EP1856141A1 (ko)
JP (1) JP4320357B2 (ko)
KR (2) KR20100090311A (ko)
CN (1) CN101128478B (ko)
AR (1) AR052392A1 (ko)
AU (1) AU2006253891B2 (ko)
BR (1) BRPI0606189A2 (ko)
CA (1) CA2599322C (ko)
MX (1) MX2007009060A (ko)
NO (1) NO20074885L (ko)
NZ (1) NZ561848A (ko)
RU (1) RU2381035C2 (ko)
TW (1) TWI366602B (ko)
WO (1) WO2006129139A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101128478B (zh) * 2005-02-25 2013-08-14 硕腾P有限责任公司 猪繁殖与呼吸综合征病毒的n蛋白突变体
AU2009303845B2 (en) * 2008-10-16 2013-09-12 Zoetis Llc Torque teno virus (TTV) isolates and compositions
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
CA2837125A1 (en) 2011-05-27 2012-12-06 Sinovet (Beijing) Biotechnology Co.,Ltd Combined vaccines for prevention of porcine virus infections
WO2012168818A1 (en) 2011-06-08 2012-12-13 Ah Usa 42 Llc Infectious clones of torque teno virus
SG195383A1 (en) * 2011-06-14 2013-12-30 Globeimmune Inc Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
WO2013163337A1 (en) * 2012-04-24 2013-10-31 The Ohio State University Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
JP6386999B2 (ja) * 2012-05-17 2018-09-05 ゾエティス・エルエルシー ブタ生殖および呼吸症候群(prrs)ウイルスに対する離乳前の効果的なワクチン接種
KR102276341B1 (ko) * 2020-01-29 2021-07-12 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 제조 방법 및 이의 용도
KR102402645B1 (ko) * 2020-01-29 2022-05-26 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 변이주 및 이를 포함하는 백신 조성물
EP4098741A4 (en) * 2020-01-29 2024-04-03 Biopoa, Inc. MUTANT STRAIN OF EUROPEAN SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS, AND VACCINE USING SAME
CN114315984B (zh) * 2021-12-29 2023-02-03 中国农业科学院兰州兽医研究所 一种用于制备prrsv基因ii型表位缺失疫苗毒株的n蛋白表位突变标记及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
NZ513289A (en) * 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2366072C (en) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
WO2002095040A1 (en) * 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
PL356274A1 (en) * 2000-01-26 2004-06-28 Boehringer Ingelheim Vetmedica Gmbh Recombinant attenuation of prrsv
CA2439254A1 (en) * 2001-03-09 2002-09-19 Boehringer Ingelheim Vetmedica Gmbh Life attenuated strains of prrs virus
CN101128478B (zh) * 2005-02-25 2013-08-14 硕腾P有限责任公司 猪繁殖与呼吸综合征病毒的n蛋白突变体

Also Published As

Publication number Publication date
JP2008531006A (ja) 2008-08-14
US7544362B1 (en) 2009-06-09
KR20070095453A (ko) 2007-09-28
CN101128478A (zh) 2008-02-20
CN101128478B (zh) 2013-08-14
KR20100090311A (ko) 2010-08-13
RU2381035C2 (ru) 2010-02-10
BRPI0606189A2 (pt) 2009-06-09
TW200641126A (en) 2006-12-01
JP4320357B2 (ja) 2009-08-26
NZ561848A (en) 2010-02-26
AR052392A1 (es) 2007-03-14
RU2007131536A (ru) 2009-03-27
CA2599322A1 (en) 2006-12-07
AU2006253891B2 (en) 2011-12-01
AU2006253891A1 (en) 2006-12-07
US8128937B2 (en) 2012-03-06
WO2006129139A1 (en) 2006-12-07
TWI366602B (en) 2012-06-21
US20090226486A1 (en) 2009-09-10
MX2007009060A (es) 2007-09-11
US20100136051A1 (en) 2010-06-03
CA2599322C (en) 2013-09-03
EP1856141A1 (en) 2007-11-21
US20090130143A1 (en) 2009-05-21
KR100996105B1 (ko) 2010-11-22

Similar Documents

Publication Publication Date Title
NO20074885L (no) N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus
DK1951882T3 (da) Nukleinsyrer, der koder for vacciner mod porcint reproduktions- og respirationssyndromvirus (PRRSV)
LTC1971366I2 (lt) Žmogaus anti-IL-23 antikūnai, kompozicijos, metodai ir panaudojimai
BRPI0510674A (pt) variantes fc otimizadas
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
NO20080246L (no) Anti-IGF1R-antistofformuleringer
ATE465176T1 (de) Il-7-varianten mit reduzierter immunogenität
NO20092052L (no) Antistoffer og immunkonjugater, og anvendelser derav
GB2438802A (en) Structure of the hepatitis C virus NS5A protein
DK1959992T3 (da) Immunogen sammensætning indeholdende en adjuvans.
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NO20084893L (no) Lyofiliserte terapeutiske peptistoffpreparater
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
DK1833508T3 (da) Virusstammer og sammensætninger af PRRS-syndromet (porcint reproduktivt og respiratorisk syndrom)
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
NO20065115L (no) Cellulaer tillatende faktor for virus, og anvendelse derav
MX2007010220A (es) Peptidos para la deteccion de anticuerpo para el virus del sindrome respiratorio reproductivo porcino.
DE502005001222D1 (de) Gasfeder
ITMI20021897A1 (it) Seggiolone con dondolo per bambini.
DK1255815T3 (da) Porcint reproduktivt og respiratorisk syndromvirus til fremgangsmåder til anvendelse
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
MX2009003300A (es) Vectores de rhinovirus recombinantes.
TW200636067A (en) Mutant porcine reproductive and respiratory syndrome virus
NO20090395L (no) Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater
NO20043489L (no) Sammensetning for inhalering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application